Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02791360 : Evaluation of Anatomy, Clinical and Neuropsychological Long-term Sequelae of Patients Treated With Radiation Therapy for Brain Tumor
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

In the case group:

- A history of solid brain tumor or haematological histologically proven.

- Patients previously treated with radiotherapy in this brain tumor (greater than or
equal to 36 Gy dose).

- Radiotherapy treatment on a tumor in place or operated.

- Decline at least 10 years from the end of radiotherapy.

- Treatment with isocentric conformal radiotherapy.

- No other radiation therapy for locally recurrent brain metastases or new brain tumor.

- Lack of known brain metastases or meningeal carcinomatosis.

For the control group:

- Patients previously treated for cancer and disease relapse free for 10 years.

- No brain radiotherapy treatment.

- Lack of treatment with anti-cancer chemotherapy.

- Women of childbearing potential must be under effective contraception.

- Pairing according to age, sex, arms director and socio-cultural level.

For two groups:

- Man or woman aged (e) of minimum 18 years.

- Topic fluent French and comprising well.

- Free and Informed Consent signed.

- The subject should be affiliated to an appropriate social security system

- No cons-indication to MRI.

- The subject must have at least one primary school level

Exclusion Criteria:

In the case group:

- Brain radiotherapy carried out by intensity modulation technique.

- Radiation dose less than 36 Gy on the brain.

- Subject with against-indication to MRI.

For the control group:

- Previous history of brain radiotherapy.

- Previous history of brain surgery.

- Central neurological disorders, such as seizures, uncontrolled.

For two groups:

- Current Topics in oral chemotherapy or intravenous.

- Subject pregnant.

- Subject is not fluent in French or including bad.

- Any geographical conditions, social or associated psychopathology that could
compromise the patient's ability to participate in the study.

- Participation in a therapeutic trial for less than 30 days.

- A person not affiliated with a social security scheme.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02791360      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740